Simona Mozzetti
Impact in
- Cell Biology top 2%
- Microtubule and mitosis dynamics
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
Papers in
-
- Epigenetics and DNA Methylation 3
- Oncology 18
- Cancer Treatment and Pharmacology 7
- Cancer-related Molecular Pathways 6
- Cancer Cells and Metastasis 3
- Co-authors
- Giovanni Scambia (33 shared papers)Cristiano Ferlini (21 shared papers)Giuseppina Raspaglio (15 shared papers)Gabriella Ferrandina (12 shared papers)Flavia Filippetti (13 shared papers)Enrica Martinelli (9 shared papers)Daniela Gallo (10 shared papers)Maria Marone (11 shared papers)
- Journals
- Cancer Research (4 papers)British Journal of Haematology (3 papers)Gene (2 papers)Clinical Cancer Research (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- ItalyUnited StatesJapan
In The Last Decade
Simona Mozzetti
35 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 105
- Cell Biology 580
- Oncology 798
- Cancer Research 403
- Molecular Biology 1.4k
- Reproductive Medicine 151
Countries citing papers authored by Simona Mozzetti
This map shows the geographic impact of Simona Mozzetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Mozzetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Mozzetti more than expected).
Fields of papers citing papers by Simona Mozzetti
This network shows the impact of papers produced by Simona Mozzetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Mozzetti. The network helps show where Simona Mozzetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Simona Mozzetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 286 | |
| 2 | Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. | 2005 | 286 |
| 3 | 2005 | 270 | |
| 4 | 2006 | 195 | |
| 5 | 2009 | 132 | |
| 6 | 2003 | 122 | |
| 7 | 2007 | 102 | |
| 8 | bcl-2, bax, bcl-XL, and bcl-XS expression in normal and neoplastic ovarian tissues. | 1998 | 95 |
| 9 | 2005 | 93 | |
| 10 | 2014 | 64 | |
| 11 | 2000 | 59 | |
| 12 | 2015 | 54 | |
| 13 | 2008 | 52 | |
| 14 | 2008 | 49 | |
| 15 | 2007 | 46 | |
| 16 | 2000 | 45 | |
| 17 | 1998 | 41 | |
| 18 | 2000 | 40 | |
| 19 | 2008 | 38 | |
| 20 | 2008 | 29 |
About Simona Mozzetti
Simona Mozzetti is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Cancer Research, having authored 35 papers that have together received 2.3k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (11 papers), Cancer Treatment and Pharmacology (7 papers), Cancer-related Molecular Pathways (6 papers), Hematopoietic Stem Cell Transplantation (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (3 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Cell Biology (580 citations), Oncology (798 citations), Cancer Research (403 citations), Molecular Biology (1.4k citations) and Reproductive Medicine (151 citations). Simona Mozzetti has collaborated with scholars based in Italy, United States and Japan. Frequent co-authors include Giovanni Scambia, Cristiano Ferlini, Giuseppina Raspaglio, Gabriella Ferrandina, Flavia Filippetti, Enrica Martinelli, Daniela Gallo, Maria Marone, Silvia Prislei and Luca Pierelli. Their work appears in journals such as Cancer Research, British Journal of Haematology, Gene, Clinical Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.